Medical Conference Accepts Clinical Study On First Use of Microvision's See-through Display in Cardiology Procedure.Business Editors, Hi-Tech Writers BOTHELL, Wash.--(BUSINESS WIRE)--Nov. 7, 2001 A clinical study detailing the first application of Microvision's (MVIS MVIS Microvision Inc (Redmond, Washington) : NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on ), retinal scanning technology in an interventional cardiology interventional cardiology Cardiology The subspecialty of cardiology dedicated to the diagnosis, medical and mechanical therapy, pre- and post-procedure management of adult patients with acute and chronic forms of cardiovascular disease amenable to catheter-based procedure has been accepted for presentation at the 10th Annual Medicine Meets Virtual Reality Conference (MMVR MMVR Medicine Meets Virtual Reality Conference ). Authored by cardiologist Mark Reisman, director of cardiovascular research and the cardiac catheterization lab at Swedish Heart Institute in Seattle, and Swedish cardiologist William Gray, the study notes the use of Microvision's Nomad(TM) Personal Display System during a procedure called patent foramen ovale patent foramen ovale PFO Cardiology An opening between the left and right atria which allows blood to bypass the lungs in utero; the FO normally closes shortly after birth, but remains open in up to 20%; a PFO is, in absence of other cardiac defects, is of no consequence (PFO PFO Patent Foramen Ovale (defect of the heart) PFO Paphos, Cyprus - International (Airport Code) PFO Principal Federal Official (US Departement of Homeland Security) ), where a hole between the upper chambers of the heart is closed. According to the study, doctors used the Nomad system - which utilizes Microvision's retinal scanning technology - to place an image equivalent to a 19 inch computer monitor just two feet from the viewer. In each of the 11 PFO procedures, the Nomad system allowed the physician to observe the optimal position of the PFO fabric seal. This placement was confirmed by the echocardiographer, and consistently preceded the observation by other team members. Specific results of this series will be presented at the MMVR conference, scheduled for Jan. 23-26 in Newport Beach, CA. The Nomad system utilizes a bright red laser diode display that contrasts with the grayscale In computing, a grayscale or greyscale digital image is an image in which the value of each pixel is a single sample. Displayed images of this sort are typically composed of shades of gray, varying from black at the weakest intensity to white at the strongest, though in of the fluoroscope fluoroscope (fl  r`əskōp), instrument consisting of an X-ray machine (see X ray) and a fluorescent screen that may be used by physicians to view the internal organs of the body. , allowing a clear differentiation of both images, potentially enhancing the speed, accuracy and safety of clinical decisions based on images, according to David Ormerod, medical segment manager for Microvision. Microvision expects to introduce the Nomad system - its first commercial product utilizing retinal scanning display technology - by the end of 2001. About Microvision: http://www.mvis.com Headquartered in Bothell, WA, Microvision Inc. is the developer of the patented retinal scanning display technology and a world leader in micro miniature optical scanning technology for display and imaging applications. The company's technology has applications in a broad range of military, medical, industrial, professional and consumer information products. NOTE: Nomad is a trademark of Microvision, Inc. Forward Looking Statement The information set forth in this release includes "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and is subject to the safe harbor created by those sections. Certain factors that realistically could cause results to differ materially from those projected in the company's forward-looking statements are set forth in the company's Annual Report on Form 10-K and Quarterly Reports on Form 10-Q, as filed with the Securities and Exchange Commission. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion